Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H22N2O |
| Molecular Weight | 246.348 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
InChI
InChIKey=INWLQCZOYSRPNW-ZDUSSCGKSA-N
InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)/t13-/m0/s1
| Molecular Formula | C15H22N2O |
| Molecular Weight | 246.348 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1101130
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1101130
Dexivacaine is a local anesthetic drug that has minimal and non-significant side effects.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1101130 |
Primary | Unknown Approved UseUnknown |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:56 GMT 2025
by
admin
on
Mon Mar 31 17:45:56 GMT 2025
|
| Record UNII |
QI846AL4NC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C245
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2558
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
C65371
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
24358-84-7
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
100000083426
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
SUB07033MIG
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
QI846AL4NC
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104634
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
3032799
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY | |||
|
DTXSID30179091
Created by
admin on Mon Mar 31 17:45:56 GMT 2025 , Edited by admin on Mon Mar 31 17:45:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |